Basics Insmed, Inc. Insmed Inc is a global biotechnology company. It is focused on developing novel therapies that focus primarily on lung diseases. IPO Date: June 1, 2000 Sector: Healthcare Industry: Biotech Market Cap: $43.51B Activated in VL: True Average Daily Range Avg Daily Range: $0.44 | 2.82% Avg Daily Range (30 D): $3.55 | 1.89% Avg Daily Range (90 D): $2.50 | 1.59% Institutional Daily Volume Avg Daily Volume: .81M Avg Daily Volume (30 D): 1.95M Avg Daily Volume (90 D): 2.01M Trade Size Avg Trade Size (Sh.): 126 Avg Trade Size (Sh.) (30 D): 49 Avg Trade Size (Sh.) (90 D): 52 Institutional Trades Total Inst.Trades: 9,176 Avg Inst. Trade: $4.2M Avg Inst. Trade (30 D): $19.79M Avg Inst. Trade (90 D): $15.03M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $8.87M Avg Closing Trade (30 D): $104.83M Avg Closing Trade (90 D): $66.65M Avg Closing Volume: 174.25K     News Nov 30, 2025 @ 8:14 AM 30% of Billionaire Stanley Druckenmiller's Portfol... Source: Bram Berkowitz Sep 8, 2025 @ 5:00 PM DPP1 Inhibitor Market Set to Reach New Heights in ... Source: Delveinsight Aug 25, 2025 @ 7:00 PM Non-cystic Fibrosis Bronchiectasis Market Ready to... Source: Delveinsight Aug 14, 2025 @ 5:00 PM Pulmonary Hypertension associated with Interstitia... Source: Delveinsight Jun 20, 2025 @ 5:37 PM Russell Rebalance: 3 Stocks Ready to Move Higher Source: Marketbeat.Com Financials   TTM Q3 2025 Q2 2025 Basic EPS $-6.19 $-1.75 $-1.7 Diluted EPS $-6.19 $-1.75 $-1.7 Revenue $ 447.02M $ 142.34M $ 107.42M Gross Profit $ 342.15M $ 112.98M $ 79.34M Net Income / Loss $ -1183.84M $ -370.02M $ -321.69M Operating Income / Loss $ -1157.44M $ -366.01M $ -312.88M Cost of Revenue $ 104.87M $ 29.37M $ 28.08M Net Cash Flow $ -126.69M $ -949.56M $ 881.08M PE Ratio     Splits Mar 03, 2011:   1:10 Jul 31, 2000:   1:4